Sino Biopharmaceutical Limited
SBMFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $51,730 | $69,064 | $75,138 | $79,282 |
| - Cash | $9,570 | $9,452 | $8,655 | $9,600 |
| + Debt | $9,784 | $12,580 | $13,982 | $12,118 |
| Enterprise Value | $51,944 | $72,192 | $80,465 | $81,800 |
| Revenue | $28,866 | $26,199 | $26,026 | $26,861 |
| % Growth | 10.2% | 0.7% | -3.1% | – |
| Gross Profit | $23,530 | $21,210 | $21,539 | $21,529 |
| % Margin | 81.5% | 81% | 82.8% | 80.1% |
| EBITDA | $6,109 | $6,979 | $6,691 | $19,874 |
| % Margin | 21.2% | 26.6% | 25.7% | 74% |
| Net Income | $3,500 | $2,332 | $2,544 | $14,608 |
| % Margin | 12.1% | 8.9% | 9.8% | 54.4% |
| EPS Diluted | 0.19 | 0.1 | 0.12 | 0.73 |
| % Growth | 90.6% | -16.9% | -83.6% | – |
| Operating Cash Flow | $6,615 | $6,066 | $6,265 | $5,366 |
| Capital Expenditures | -$960 | -$1,704 | -$1,706 | -$1,894 |
| Free Cash Flow | $5,655 | $4,362 | $4,560 | $3,472 |